For animal use only.
A polyvalent inactivated vaccine for the prevention of Clostridial infections in cattle and sheep.
COMPOSITION
This vaccine contains antigens in sufficient quantities to obtain the following levels of antibodies in the serum of control animals:
Cl. perfringens type A, C and D:
Alpha toxoid 2 IU/ml
Beta toxoid 10 IU/ml
Epsilon toxoid 5 IU/ml
Cl. septicum toxoid 2,5 IU/ml
Cl. novyi type B toxoid 3,5 IU/ml
Cl. tetani toxoid 2,5 IU/ml
Cl. Chauvoei 100% protection
Adjuvant aluminium hydroxide as Al(OH)₃ q.s. 0,6 - 0,8%
Preservative formaldehyde q.s. <0,05%
DIRECTIONS FOR USE
Use only as directed.
Shake well before use.
After first opening of the container, it is recommended to use the vaccine within 8 hours.
Administration is by subcutaneous injection in the loose skin on the upper side of the neck.
No alcohol or any other disinfectants should be used for sterilisation of the needles and syringes.
DOSAGE
SHEEP:
Non pregnant ewes, rams | First vaccination: 2 ml at any time | Booster: 2 ml 4 weeks after 1st injection | 2 ml one year after last injection or 4 - 6 weeks prior to challenge period.
Pregnant ewes | First vaccination: 2 ml 6 - 9 weeks before expected lambing date | Booster: 2 ml 4 weeks after 1st injection and not later than 2 - 5 weeks prior to expected lambing date | 2 ml one year after last injection or not later than 2 - 5 weeks before expected lambing date.
Lambs | First vaccination: 2 ml at two weeks of age (unvaccinated). If ewe was previously vaccinated, start vaccination at 8 weeks of age. | Booster: 2 ml 4 weeks after 1st injection | 2 ml one year after last injection or 4 - 6 weeks prior to challenge period.
CATTLE:
Calves weighing less than 100 kg | First vaccination: 2 ml at any time | Booster: 2 ml 6 weeks after 1st injection | 4 ml one year after last injection or not later than 2 - 4 weeks prior to risk period.
Calves and adult cattle | First vaccination: 4 ml at any time | Booster: 4 ml 6 weeks after 1st injection | 4 ml one year after last injection or 4 - 6 weeks prior to challenge period.
EFFICACY
For the active immunisation of cattle and sheep against infections caused by Cl. perfringens A, C and D, Cl. novyi B, Cl. septicum, Cl. tetani and Cl. chauvoei in the following bacterial disease conditions:
- Pulpy Kidney Disease in sheep
- Black Quarter in cattle and sheep
- Gas Gangrene in cattle and sheep
- Tetanus in cattle and sheep
- Malignant Oedema in cattle and sheep
- Enterotoxaemia (bloodgut) in adult sheep and lambs
STORAGE
Store between 2 - 8 °C.
Protect from light.
Do not freeze.
PACKING SIZE AND ORDERING CODE
100 ml (LVS97893)
250 ml (LVS98069)
500 ml (LVS99685)
Reg. no. G3684 (36/1947)
Reg. holder: CEVA Animal Health (Pty) Ltd, Reg. No. 1973/016009/07, PO Box 7707, Halfway House, 1685 | Tel: 011 312 4088
COGLAVAX®
- Vaccinate healthy animals only.
- The vaccine contains an adjuvant which may result in a mild, temporary local reaction at the site of injection.
- A small number of individuals may fail to develop an immune response in any group of animals as a result of immuno-incompetence or for other reasons.
- As with most inactivated vaccines, significant development of immunity cannot be expected until two weeks after the second dose of the vaccination course. During the vaccination process, stressing of the animals should be avoided, particularly during the later stages of pregnancy when there is an increased risk of induction of abortion and metabolic disease conditions.
- Occasional hypersensitivity reactions may occur.
- Keep out of reach of children, uninformed persons and animals.
- Although this vaccine has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.
- Observe the usual aseptic precautions in the administration of this vaccine.
- Do not mix with any other vaccine.
- In case of accidental self-injection to the user, immediately consult a doctor.
- Destroy any partially used packs by for example burning; dispose of all the vaccine containers when the vaccination is completed.
- It is good vaccination practice not to allow vaccine to come into contact with human eyes or mucous membranes.
- Wash and disinfect hands with a disinfectant after vaccination.